Translation plan and controlled terminology notes
Practical, reviewable, and ready for the owner who needs to act, approve, or respond.
PharmaRevix supports PI and DMF translation, label and artwork preparation, mock-up review, and lifecycle artwork management across regional requirements.
Practical, reviewable, and ready for the owner who needs to act, approve, or respond.
Practical, reviewable, and ready for the owner who needs to act, approve, or respond.
Practical, reviewable, and ready for the owner who needs to act, approve, or respond.
Practical, reviewable, and ready for the owner who needs to act, approve, or respond.
Practical, reviewable, and ready for the owner who needs to act, approve, or respond.
Practical, reviewable, and ready for the owner who needs to act, approve, or respond.
Confirm label scope, countries, and source text
Translate and adapt content to local expectations
Review artwork, mock-ups, and regulatory claims
Prepare controlled lifecycle handoff
The work is designed for real review: authority questions, partner due diligence, quality audits, and internal leadership updates.
Captured with owners, assumptions, decision rationale, and next actions so the work can continue smoothly.
Captured with owners, assumptions, decision rationale, and next actions so the work can continue smoothly.
Captured with owners, assumptions, decision rationale, and next actions so the work can continue smoothly.
Captured with owners, assumptions, decision rationale, and next actions so the work can continue smoothly.
PharmaRevix supports new applications, variations, renewals, annual reports, eCTD publishing, and MAH-related regulatory operations across key markets.
Explore serviceLeverage existing EU or US approvals and adapt the dossier intelligently for each country. PharmaRevix helps you prioritize markets, coordinate local representatives, and keep submissions moving.
Explore servicePharmaRevix supports Module 1-5 compilation, baseline conversion, sequence management, validation, and submission-ready publishing across modern eCTD toolchains.
Explore serviceShort answers for teams deciding whether this is the right next step.
Ask us anythingTalk with PharmaRevix about scope, timelines, and the cleanest next step for your market or safety obligation.